BMJ publishes research suggesting paracetamol is "ineffective" in low back pain

2 April 2015
lots-of-pills-big
Deposit Photos

Research published by the British Medical Journal has suggested that paracetamol provides “minimal short-term benefit” in osteoarthritis, and is “ineffective” in treating low back pain.

Study authors analyzed data from 13 randomized studies, and concluded that the data suggested recommendations to use paracetamol in these patients should be re-evaluated. The results showed that paracetamol is inefficient in reducing pain intensity and disability or improving short-term quality of life in patients with low back pain. In hip or knee osteoarthritis, there was evidence that the drug provides a significant but not clinically important effect on short-term pain and disability.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight



More Features in Pharmaceutical